Drastic Reduction in CRISPR Off-Target Effects by IDT’s New Cas9 Enzyme
Reduction of CRISPR off-target effects without significant loss of on-target activity
Reduction of CRISPR off-target effects without significant loss of on-target activity
Innova CEO and CSO Dr. Nick Gee becomes Chief Technical Officer of SYGNIS
Emphasis will be on bioanalytical, food safety, forensics, pharmaceutical science, nanotechnology, say organisers of next year’s Pittsburgh Conference
ImageXpress Nano System makes automated imaging accessible for every lab conducting cellular imaging research
Firms to co-market new semi-automated sample preparation approach for protein therapeutics glycosylation profiling
Next-generation columns are easy to install and reduce chromatographic variability during proteomics and biomarker research
Customizable software and cloud-based tools help scientists be more productive to help accelerate metabolomic and proteomic discoveries
Visit Binding Site at stand #8 or attend workshop on June 13
Dream big, don’t be limited by current opinion and don’t be afraid to make mistakes – co-CEO Dr. Stefan Duhr shares his tips for success and more
Kit increases efficiency of residual protein A ligand detection